Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue

Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regu...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 168; no. 6; pp. 2979 - 2987
Main Authors McEvoy, Alice N., Murphy, Eithne A., Ponnio, Tiia, Conneely, Orla M., Bresnihan, Barry, FitzGerald, Oliver, Murphy, Evelyn P.
Format Journal Article
LanguageEnglish
Published United States 15.03.2002
Subjects
Online AccessGet full text
ISSN0022-1767
1550-6606
DOI10.4049/jimmunol.168.6.2979

Cover

Loading…
Abstract Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE2, IL-1β, and TNF-α markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1β and TNF-α requires a proximal promoter region that contains a consensus NF-κB DNA-binding motif. IL-1β- and TNF-α-induced NF-κB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE2 situated at promoter region −171/−163. Moreover, analyses confirm the presence of CREB-1 and NF-κB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-κB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE2-, TNF-α-, and IL-1β-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.
AbstractList Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE sub(2), IL-1 beta , and TNF- alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1 beta and TNF- alpha requires a proximal promoter region that contains a consensus NF- Kappa B DNA-binding motif. IL-1 beta - and TNF- alpha -induced NF- Kappa B binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE sub(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF- Kappa B p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF- Kappa B- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE sub(2)-, TNF- alpha -, and IL-1 beta -dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.
Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE(2), IL-1beta, and TNF-alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1beta and TNF-alpha requires a proximal promoter region that contains a consensus NF-kappaB DNA-binding motif. IL-1beta- and TNF-alpha-induced NF-kappaB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-kappaB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE(2)-, TNF-alpha-, and IL-1beta-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.
Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE(2), IL-1beta, and TNF-alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1beta and TNF-alpha requires a proximal promoter region that contains a consensus NF-kappaB DNA-binding motif. IL-1beta- and TNF-alpha-induced NF-kappaB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-kappaB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE(2)-, TNF-alpha-, and IL-1beta-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE(2), IL-1beta, and TNF-alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1beta and TNF-alpha requires a proximal promoter region that contains a consensus NF-kappaB DNA-binding motif. IL-1beta- and TNF-alpha-induced NF-kappaB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-kappaB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE(2)-, TNF-alpha-, and IL-1beta-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.
Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE2, IL-1β, and TNF-α markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1β and TNF-α requires a proximal promoter region that contains a consensus NF-κB DNA-binding motif. IL-1β- and TNF-α-induced NF-κB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE2 situated at promoter region −171/−163. Moreover, analyses confirm the presence of CREB-1 and NF-κB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-κB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE2-, TNF-α-, and IL-1β-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.
Author Murphy, Eithne A.
Murphy, Evelyn P.
Conneely, Orla M.
Ponnio, Tiia
McEvoy, Alice N.
Bresnihan, Barry
FitzGerald, Oliver
Author_xml – sequence: 1
  givenname: Alice N.
  surname: McEvoy
  fullname: McEvoy, Alice N.
– sequence: 2
  givenname: Eithne A.
  surname: Murphy
  fullname: Murphy, Eithne A.
– sequence: 3
  givenname: Tiia
  surname: Ponnio
  fullname: Ponnio, Tiia
– sequence: 4
  givenname: Orla M.
  surname: Conneely
  fullname: Conneely, Orla M.
– sequence: 5
  givenname: Barry
  surname: Bresnihan
  fullname: Bresnihan, Barry
– sequence: 6
  givenname: Oliver
  surname: FitzGerald
  fullname: FitzGerald, Oliver
– sequence: 7
  givenname: Evelyn P.
  surname: Murphy
  fullname: Murphy, Evelyn P.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11884470$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAURi1U1E5LnwAJecUug-0kTrycjlpAKtNqmK4tx75hXCV2sJ1Ks-OZECsegofokzT9Y8GCSvfqbs73Le45RHvOO0DoLSXzghTiw7Xt-9H5bk55PedzJirxCs1oWZKMc8L30IwQxjJa8eoAHcZ4TQjhhBX76IDSui6KiszQr4VO9kYl6x32LV6NugMV8EUYtsrhNWgYkg94dbVeU7wJykUd7PCANzu8Osv-_D7Byhm83OnOarww4Hy0DnB5--Nn9sU7P2x9nNoSTHVx8C4CPu2gB5eyE-uMdd_wZfAJrMPTrLcw9ip5a_AipG2wyUb8def8jVUd3tgYR3iDXreqi3D8dI_Q1dnpZvkpO7_4-Hm5OM90nrOUlQZaVetpTcMbUeU6V5VhgjVasKJtmSaqZNSUTdGYRhDKwDDgZnpuofIc8iP0_rF3CP77CDHJ3kYNXacc-DHKipYk56J-EaQ1EwUrqwl89wSOTQ9GDsH2Kuzks5AJEI-ADj7GAK3UNj3oSUHZTlIi7-XLZ_lyki-5vJc_ZfN_sn_r_5O6Ax5Fu8c
CitedBy_id crossref_primary_10_1186_1476_9255_2_15
crossref_primary_10_1186_s12885_016_2291_4
crossref_primary_10_1071_RD14315
crossref_primary_10_1016_j_neuro_2014_04_010
crossref_primary_10_1111_j_1460_9568_2004_03204_x
crossref_primary_10_1016_j_brainres_2016_09_031
crossref_primary_10_1074_jbc_M502606200
crossref_primary_10_1111_j_1600_0625_2006_00382_x
crossref_primary_10_1002_chem_200701033
crossref_primary_10_1097_00001756_200401190_00020
crossref_primary_10_18632_oncotarget_20747
crossref_primary_10_1016_j_jbspin_2015_09_001
crossref_primary_10_3389_fimmu_2021_676644
crossref_primary_10_1007_s12079_010_0104_0
crossref_primary_10_1093_carcin_bgp161
crossref_primary_10_1074_jbc_M300088200
crossref_primary_10_1016_j_canlet_2020_09_025
crossref_primary_10_1124_mol_104_005801
crossref_primary_10_1165_rcmb_2013_0198OC
crossref_primary_10_1002_prp2_973
crossref_primary_10_4049_jimmunol_1701250
crossref_primary_10_1371_journal_pone_0109047
crossref_primary_10_4049_jimmunol_175_1_555
crossref_primary_10_1074_jbc_M507752200
crossref_primary_10_1002_art_20157
crossref_primary_10_1016_j_neulet_2020_135468
crossref_primary_10_1007_s00401_015_1422_3
crossref_primary_10_1038_s12276_021_00555_5
crossref_primary_10_3389_fphar_2022_835697
crossref_primary_10_1186_s12864_016_2469_9
crossref_primary_10_1210_me_2005_0331
crossref_primary_10_1016_j_jsbmb_2011_01_010
crossref_primary_10_1186_s11658_017_0046_0
crossref_primary_10_1016_j_gene_2020_145059
crossref_primary_10_1016_j_lfs_2012_07_003
crossref_primary_10_2353_ajpath_2010_091204
crossref_primary_10_3109_1354750X_2012_706641
crossref_primary_10_3390_ijms20194858
crossref_primary_10_1046_j_1462_5822_2003_00319_x
crossref_primary_10_1161_01_ATV_0000098644_03153_6F
crossref_primary_10_1136_ard_2009_111690
crossref_primary_10_1002_jcp_28044
crossref_primary_10_1038_sj_jid_5701023
crossref_primary_10_1002_ijc_25600
crossref_primary_10_1016_j_kint_2019_04_009
crossref_primary_10_1002_art_34399
crossref_primary_10_3390_biology10050423
crossref_primary_10_1038_nn_3932
crossref_primary_10_1186_1471_2164_12_610
crossref_primary_10_1074_jbc_M111_272427
crossref_primary_10_1002_art_34554
crossref_primary_10_1074_jbc_M309260200
crossref_primary_10_1002_ajmg_a_35873
crossref_primary_10_1016_j_bbrc_2009_01_086
crossref_primary_10_1007_s00109_019_01866_x
crossref_primary_10_1016_j_ajpath_2013_06_029
crossref_primary_10_1097_00002281_200307000_00003
crossref_primary_10_1042_BJ20050196
crossref_primary_10_4049_immunohorizons_1900043
crossref_primary_10_1016_j_jsbmb_2015_04_016
crossref_primary_10_1038_s41598_019_52085_w
crossref_primary_10_1016_j_brainresrev_2004_04_007
crossref_primary_10_1016_j_molimm_2018_05_024
crossref_primary_10_3389_fimmu_2019_00085
crossref_primary_10_1016_j_biopha_2024_117802
crossref_primary_10_1111_j_0022_202X_2005_23932_x
crossref_primary_10_1002_art_24534
crossref_primary_10_1161_CIRCULATIONAHA_109_885673
crossref_primary_10_1002_stem_122
crossref_primary_10_1016_j_mam_2021_100942
crossref_primary_10_1093_carcin_bgh135
crossref_primary_10_1128_MCB_00385_13
crossref_primary_10_3390_receptors2040018
crossref_primary_10_1016_j_carres_2006_04_041
crossref_primary_10_1002_jmv_29025
crossref_primary_10_1186_s12950_015_0059_2
crossref_primary_10_3389_fnmol_2020_00064
crossref_primary_10_1016_j_molimm_2009_07_019
crossref_primary_10_1111_j_1471_4159_2008_05432_x
crossref_primary_10_1016_j_bbrc_2021_03_082
crossref_primary_10_1111_j_0105_2896_2009_00852_x
crossref_primary_10_1111_j_1476_5381_2011_01817_x
crossref_primary_10_1007_s11095_010_0117_7
crossref_primary_10_2353_ajpath_2007_061000
crossref_primary_10_1007_s10059_010_0015_1
crossref_primary_10_1074_jbc_M116_714873
crossref_primary_10_33549_physiolres_935168
crossref_primary_10_4049_jimmunol_1601301
crossref_primary_10_1210_en_2007_1202
crossref_primary_10_1074_jbc_M608327200
Cites_doi 10.1002/1529-0131(200008)43:8<1673::AID-ANR2>3.0.CO;2-Y
10.1016/0014-5793(95)00956-A
10.1128/mcb.14.5.3469-3483.1994
10.1016/S0021-9258(18)52952-5
10.1007/BF01375656
10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D
10.1016/S0378-1119(96)00736-6
10.1172/JCI112350
10.1093/hmg/4.12.2219
10.1093/rheumatology/31.10.653
10.1126/science.3283939
10.1016/S0378-1119(99)00065-7
10.4049/jimmunol.167.1.469
10.1210/mend.6.9.1331771
10.1172/JCI8298
10.1210/mend.11.1.9874
10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V
10.1006/bbrc.1994.2900
10.1016/S0092-8674(00)80413-4
10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.0.CO;2-H
10.1083/jcb.102.3.697
10.1056/NEJM200103223441207
10.1210/mend.8.11.7877627
10.1002/art.1780310302
10.3109/08916939808995367
10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.0.CO;2-8
10.1016/S0021-9258(17)44894-0
10.1016/0092-8674(89)90237-7
10.1016/0896-6273(88)90138-9
10.1210/mend.6.12.1491694
10.1002/art.1780400207
10.1172/JCI3756
10.1002/1529-0131(200108)44:8<1761::AID-ART311>3.0.CO;2-D
10.1002/art.1780380202
10.1210/endo.142.2.7926
10.1016/0092-8674(95)90199-X
10.1084/jem.173.3.569
10.1056/NEJM199005033221805
10.1073/pnas.85.22.8444
10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I
10.1172/JCI11830
10.1210/endo.141.7.7562
10.1128/MCB.13.10.6124
10.1136/ard.57.8.487
10.1126/science.1925541
10.1136/ard.52.Suppl_1.S39
10.1002/art.1780391103
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.4049/jimmunol.168.6.2979
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 2987
ExternalDocumentID 11884470
10_4049_jimmunol_168_6_2979
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
5WD
79B
85S
AARDX
AAYXX
ABCQX
ABDFA
ABDPE
ABEFU
ABEJV
ABGNP
ABJNI
ABOCM
ABPPZ
ABXVV
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADIPN
ADNWM
ADXHL
AENEX
AETEA
AFFNX
AFHIN
AFOSN
AFRAH
AGORE
AHMMS
AHWXS
AI.
AIZAD
ALMA_UNASSIGNED_HOLDINGS
ARBBW
BAWUL
BCRHZ
BTFSW
CITATION
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
IH2
J5H
K-O
KQ8
L7B
MVM
NEJ
OCZFY
OK1
OWPYF
P0W
P2P
PQQKQ
R.V
RHI
ROX
RZQ
SJN
SKT
TR2
TWZ
VH1
W8F
WH7
WOQ
X7M
XJT
XSW
XTH
YHG
ZE2
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
UMC
7T5
H94
KOP
7X8
ID FETCH-LOGICAL-c332t-5defa8cfa8db6b973c3a7d292bc924ff2c0a521d5b4bdb9012ed2e6d0494a33e3
ISSN 0022-1767
IngestDate Fri Sep 05 07:30:51 EDT 2025
Thu Sep 04 20:17:22 EDT 2025
Fri May 23 03:14:12 EDT 2025
Tue Jul 01 01:03:10 EDT 2025
Thu Apr 24 23:12:37 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c332t-5defa8cfa8db6b973c3a7d292bc924ff2c0a521d5b4bdb9012ed2e6d0494a33e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 11884470
PQID 18294257
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_71503698
proquest_miscellaneous_18294257
pubmed_primary_11884470
crossref_citationtrail_10_4049_jimmunol_168_6_2979
crossref_primary_10_4049_jimmunol_168_6_2979
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2002-03-15
2002-Mar-15
20020315
PublicationDateYYYYMMDD 2002-03-15
PublicationDate_xml – month: 03
  year: 2002
  text: 2002-03-15
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2002
References 2022123116294513400_R16
2022123116294513400_R17
2022123116294513400_R18
2022123116294513400_R19
2022123116294513400_R23
2022123116294513400_R24
2022123116294513400_R25
2022123116294513400_R26
2022123116294513400_R20
2022123116294513400_R21
2022123116294513400_R22
2022123116294513400_R49
2022123116294513400_R50
2022123116294513400_R51
2022123116294513400_R12
2022123116294513400_R13
2022123116294513400_R14
2022123116294513400_R15
2022123116294513400_R52
2022123116294513400_R10
2022123116294513400_R11
2022123116294513400_R38
2022123116294513400_R39
2022123116294513400_R2
2022123116294513400_R1
2022123116294513400_R4
2022123116294513400_R3
2022123116294513400_R6
2022123116294513400_R5
2022123116294513400_R8
2022123116294513400_R7
2022123116294513400_R9
2022123116294513400_R40
2022123116294513400_R45
2022123116294513400_R46
2022123116294513400_R47
2022123116294513400_R48
2022123116294513400_R41
2022123116294513400_R42
2022123116294513400_R43
2022123116294513400_R44
2022123116294513400_R27
2022123116294513400_R28
2022123116294513400_R29
2022123116294513400_R34
2022123116294513400_R35
2022123116294513400_R36
2022123116294513400_R37
2022123116294513400_R30
2022123116294513400_R31
2022123116294513400_R32
2022123116294513400_R33
References_xml – ident: 2022123116294513400_R33
  doi: 10.1002/1529-0131(200008)43:8<1673::AID-ANR2>3.0.CO;2-Y
– ident: 2022123116294513400_R35
  doi: 10.1016/0014-5793(95)00956-A
– ident: 2022123116294513400_R26
  doi: 10.1128/mcb.14.5.3469-3483.1994
– ident: 2022123116294513400_R24
  doi: 10.1016/S0021-9258(18)52952-5
– ident: 2022123116294513400_R36
  doi: 10.1007/BF01375656
– ident: 2022123116294513400_R42
  doi: 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D
– ident: 2022123116294513400_R38
  doi: 10.1016/S0378-1119(96)00736-6
– ident: 2022123116294513400_R4
  doi: 10.1172/JCI112350
– ident: 2022123116294513400_R28
  doi: 10.1093/hmg/4.12.2219
– ident: 2022123116294513400_R8
– ident: 2022123116294513400_R6
  doi: 10.1093/rheumatology/31.10.653
– ident: 2022123116294513400_R11
  doi: 10.1126/science.3283939
– ident: 2022123116294513400_R39
  doi: 10.1016/S0378-1119(99)00065-7
– ident: 2022123116294513400_R30
– ident: 2022123116294513400_R45
  doi: 10.4049/jimmunol.167.1.469
– ident: 2022123116294513400_R14
  doi: 10.1210/mend.6.9.1331771
– ident: 2022123116294513400_R52
  doi: 10.1172/JCI8298
– ident: 2022123116294513400_R21
  doi: 10.1210/mend.11.1.9874
– ident: 2022123116294513400_R20
– ident: 2022123116294513400_R2
  doi: 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V
– ident: 2022123116294513400_R19
  doi: 10.1006/bbrc.1994.2900
– ident: 2022123116294513400_R50
  doi: 10.1016/S0092-8674(00)80413-4
– ident: 2022123116294513400_R31
  doi: 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.0.CO;2-H
– ident: 2022123116294513400_R37
  doi: 10.1083/jcb.102.3.697
– ident: 2022123116294513400_R10
  doi: 10.1056/NEJM200103223441207
– ident: 2022123116294513400_R17
  doi: 10.1210/mend.8.11.7877627
– ident: 2022123116294513400_R34
  doi: 10.1002/art.1780310302
– ident: 2022123116294513400_R51
  doi: 10.3109/08916939808995367
– ident: 2022123116294513400_R41
  doi: 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.0.CO;2-8
– ident: 2022123116294513400_R5
  doi: 10.1016/S0021-9258(17)44894-0
– ident: 2022123116294513400_R13
  doi: 10.1016/0092-8674(89)90237-7
– ident: 2022123116294513400_R23
  doi: 10.1016/0896-6273(88)90138-9
– ident: 2022123116294513400_R15
  doi: 10.1210/mend.6.12.1491694
– ident: 2022123116294513400_R48
– ident: 2022123116294513400_R40
  doi: 10.1002/art.1780400207
– ident: 2022123116294513400_R43
  doi: 10.1172/JCI3756
– ident: 2022123116294513400_R32
  doi: 10.1002/1529-0131(200108)44:8<1761::AID-ART311>3.0.CO;2-D
– ident: 2022123116294513400_R44
  doi: 10.1002/art.1780380202
– ident: 2022123116294513400_R29
– ident: 2022123116294513400_R27
  doi: 10.1210/endo.142.2.7926
– ident: 2022123116294513400_R12
  doi: 10.1016/0092-8674(95)90199-X
– ident: 2022123116294513400_R3
  doi: 10.1084/jem.173.3.569
– ident: 2022123116294513400_R1
  doi: 10.1056/NEJM199005033221805
– ident: 2022123116294513400_R16
  doi: 10.1073/pnas.85.22.8444
– ident: 2022123116294513400_R9
  doi: 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I
– ident: 2022123116294513400_R49
  doi: 10.1172/JCI11830
– ident: 2022123116294513400_R22
  doi: 10.1210/endo.141.7.7562
– ident: 2022123116294513400_R25
  doi: 10.1128/MCB.13.10.6124
– ident: 2022123116294513400_R47
  doi: 10.1136/ard.57.8.487
– ident: 2022123116294513400_R18
  doi: 10.1126/science.1925541
– ident: 2022123116294513400_R7
  doi: 10.1136/ard.52.Suppl_1.S39
– ident: 2022123116294513400_R46
  doi: 10.1002/art.1780391103
SSID ssj0006024
Score 2.0472486
Snippet Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 2979
SubjectTerms Arthritis, Rheumatoid - genetics
Arthritis, Rheumatoid - metabolism
Arthritis, Rheumatoid - pathology
Cells, Cultured
CREB-1 protein
Cyclic AMP Response Element-Binding Protein - metabolism
Cyclic AMP Response Element-Binding Protein - physiology
Dinoprostone - pharmacology
DNA - metabolism
DNA-Binding Proteins
Humans
Inflammation Mediators - pharmacology
interleukin 1^b
Interleukin-1 - pharmacology
NF-kappa B - metabolism
NF-kappa B - physiology
Nuclear Receptor Subfamily 4, Group A, Member 2
NURR1 protein
Promoter Regions, Genetic - drug effects
Protein Binding - drug effects
Protein Binding - genetics
Receptors, Cytoplasmic and Nuclear - biosynthesis
Receptors, Cytoplasmic and Nuclear - genetics
Receptors, Cytoplasmic and Nuclear - metabolism
Synovial Membrane - drug effects
Synovial Membrane - metabolism
Synovial Membrane - pathology
Transcription Factors - biosynthesis
Transcription Factors - genetics
Transcription Factors - metabolism
Transcription, Genetic - drug effects
Tumor Necrosis Factor-alpha - pharmacology
Title Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue
URI https://www.ncbi.nlm.nih.gov/pubmed/11884470
https://www.proquest.com/docview/18294257
https://www.proquest.com/docview/71503698
Volume 168
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2FIhAvCMotXPeBiofgNFnfso8pSlUhJaCqkfpm7c1KRPFGqVMpfBgfwhcx4_UliRoESIkV-bK2c453Z9YzZwh5PzAy1CIN4UlTgRf4QniyLyOP-xzG-9TXRuN8x3gSnU2Dz5fhZav1ayNqaZXLrvpxa17J_6AK6wBXzJL9B2TrRmEF_AZ8YQkIw_KvMB6qqjiZi8dQWAOiY-GvE5ilghErdtmZTM_P-1gLImu6CDA6J6feN7FYiM6Jy21bK9S7FhrVw9H0DI9Y7MGt2MXMXkOLORZYKQJqTce4oHN0q7VLZ7dYNbNIjpmZFVjBdq5RP2lWaCahLoK9cRkqiPOmRdzkpjn5CsxXcbpQR8Xbt97GXMVYjW7c3OEQrtU0r5Eauozm-QwuvublV5tlc-tYOW-ikjC8x7gi21-WV6KcE65mPxiGf7n8z41shH7sSnrUPXo02KDuVv_MXema3YEjAEcJB47yJrvQQjfq7u4N6C--F1wCt2wQBK7kyY5ed7XpDrnLwHUpyolcNmFHUY8FlYI9XrdTwsLzH99ydtS0LdvbNpz2eEOFVXTxiDwsgaNDx83HpGWyQ3LPFThdH5L74zJ04wn52ZCV2pSWZKWOrLQiKy3ISrfISuWaVmSlJxTISh1ZaU1WGn7YpiqtqEp3qEpLqlL4NFSlNVVpRVXqqPqUTE9HF5_OvLJoiKd8n-VeqE0qBgq-WkaSx77yRawZZ1JxFqQpUz0BJqsOZSC1BGuYGc1MpFEnSfi-8Z-Rg8xm5gWhrCe46fE0BqcDjuRSMS5Z32exEeD4yzZhFSKJKhX1sbDLVQKeNSKaVIgmgGgSJYhom3ysD1o4QZk_7_6ugjqBjh_f5onM2NV10h8wjgPu_j1icPb8iA_a5LnjSHPCklMv9255RR40j9trcpAvV-YNmN-5fFvw-Td62-M4
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+nuclear+orphan+receptor+NURR1+transcription+by+NF-kappa+B+and+cyclic+adenosine+5%27-monophosphate+response+element-binding+protein+in+rheumatoid+arthritis+synovial+tissue&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=McEvoy%2C+Alice+N&rft.au=Murphy%2C+Eithne+A&rft.au=Ponnio%2C+Tiia&rft.au=Conneely%2C+Orla+M&rft.date=2002-03-15&rft.issn=0022-1767&rft.volume=168&rft.issue=6&rft.spage=2979&rft_id=info:doi/10.4049%2Fjimmunol.168.6.2979&rft_id=info%3Apmid%2F11884470&rft.externalDocID=11884470
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon